172@29@16@35!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Bafna Pharmaceuticals Ltd.

BSE: 532989 | NSE: BAFNAPHARM | Series: NA | ISIN: INE878I01022 | SECTOR: Pharmaceuticals

BSE Live

Oct 23, 16:00
27.04 1.28 (4.97%)
Volume
AVERAGE VOLUME
5-Day
168
10-Day
179
30-Day
146
1
  • Prev. Close

    25.76

  • Open Price

    27.04

27.04

Today’s L/H

27.04
5.25

52 Wk L/H

27.04
24.48

L/U Price Band

27.04
  • Bid Price (Qty.)

    27.04 (110103)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    27.04
     Beta
    0.37
  • Market Depth (23 Oct 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    157613 27.04 0.00 0
    96 25.80 0.00 0
    13306 25.76 0.00 0
    90 25.75 0.00 0
    100 25.00 0.00 0
    112369 Total Total 0
     Market Depth
    BUY 1.12 L
    SELL 0.00
    0%
    0%

NSE Live

Aug 23, 15:31
3.55 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    3.55

  • Open Price

    3.70

3.55

Today’s L/H

3.85
3.55

52 Wk L/H

21.85
3.40

L/U Price Band

3.70
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    3.70
     Beta
    0.59
  • DELIVERY AVERAGES
    3-Day
    67.83%
    5-Day
    68.29%
    8-Day
    68.03%
    Deliverables
  • SMA
    30
    50
    150
    200
    SMA
Bafna Pharmaceuticals is not traded on NSE in the last 30 days
Powered by Trendlyne

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bearish
Moving Averages Bearish
Technical Indicators Bearish
Moving Averages Crossovers Bearish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 3.75 3.95 4.05 3.65 3.45 3.35 3.15
Fibonacci 3.76 3.84 3.95 3.65 3.54 3.46 3.35
Camarilla 3.58 3.60 3.63 3.65 3.52 3.50 3.47

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 3.88
10 4.20
20 4.83
50 5.51
100 7.25
200 9.34
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 4.28 5.02 5.38 3.92 3.18 2.82 2.08
Fibonacci 4.34 4.60 5.02 3.92 3.50 3.24 2.82
Camarilla 3.65 3.75 3.85 3.92 3.45 3.35 3.25

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 4.98 6.42 7.13 4.27 2.83 2.12 0.68
Fibonacci 5.09 5.60 6.42 4.27 3.45 2.94 2.12
Camarilla 3.75 3.94 4.14 4.27 3.35 3.16 2.96

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      63.97
    • P/E
      -
    • Book Value (Rs)
      30.54
    • Dividend (%)
      -
    • Market Lot
      1
    • Industry P/E
      36.59
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      0.89
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      67.83
      5-Day
      68.29
      8-Day
      68.03
      69.27

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      63.97
    • P/E
      -
    • Book Value (Rs)
      30.64
    • Dividend (%)
      -
    • Market Lot
      1
    • Industry P/E
      36.59
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      0.88
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      67.83
      5-Day
      68.29
      8-Day
      68.03
      69.27

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 88% BUY
  • 0% SELL
  • 12% HOLD
88%
of moneycontrol users recommend buying Bafna Pharma

What's your call on Bafna Pharma today?

Read 11 investor views

BUY SELL HOLD

Action in Bafna Pharmaceuticals Ltd.

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 22, 14:40

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 21, 10:20

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 20, 15:15

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 19, 10:10

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 16, 12:45

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 15, 12:20

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 14, 12:40

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 13, 14:25

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 12, 11:50

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 09, 14:50

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 08, 12:40

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 06, 12:50

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Oct 05, 10:05

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Sep 28, 10:05

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Sep 24, 10:10

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Sep 18, 13:45

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Sep 17, 10:40

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Sep 15, 11:45

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Sep 07, 13:45

  • Only Buyers

    Only Buyers in Bafna Pharma on BSE

    Aug 31, 13:20

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded

NSE

Oct 25, 09:15
3.70 0.15 (4.23%)
High 3.70
Low
Prev. Close 3.55

Financials

(Rs. Cr)
Quarterly JUN 2020 MAR 2020 DEC 2019 SEP 2019 JUN 2019
Sales
16 13 10 11 6
Other Income
0 -0 0 0 0
Total Income
16 12 10 12 7
Total Expenditure
15 11 33 12 10
EBIT
1 1 -22 -0 -3
Interest
0 0 -0 0 0
Tax
-- 1 -0 0 -1
Net Profit
1 -0 -22 -0 -2

Historical Prices

On
Current Price %Gain / Loss
No Record Found
On
Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11930.40 33.90 0.28
SENSEX 40685.50 127.01 0.31
NIFTY BANK 24478.30 -5.85 -0.02
NIFTY IT 21523.60 110.10 0.51
S&P BSE Smallcap 15134.59 106.51 0.71
Index Price Change %Chg
Nasdaq (Oct 24) 11,548.28 42.27 0.37
DAX (Oct 23) 12,645.75 102.69 0.82
FTSE (Oct 23) 5,860.28 74.63 1.29
CAC (Oct 23) 4,909.64 58.26 1.20
SGX Nifty (Oct 24) 11,970.00 35.00 0.29

CORPORATE ACTION

Date Agenda
Sep 10, 2020 Quarterly Results
Jun 25, 2020 Audited Results
Feb 13, 2020 Quarterly Results
Nov 13, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 6.00 Sep 19, 2013
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Bafna Pharmaceuticals
Old FV New FV Ex-Split
No Splits Information is available for Bafna Pharmaceuticals
Ratio Premium Ex-Bonus
No Rights Information is available for Bafna Pharmaceuticals
Date Agenda
Jul 31, 2020 -
- Reduction of Capital
Jun 27, 2019 -
Sep 29, 2018 -
Sep 30, 2017 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2020 March 2020 March 2019 December 2018
Promoters 92.64 26.4 26.36 26.36
Pledged 1.45 50.96 32.95 51.04
FII/FPI 0 0 0 0
Total DII 1.13 11.39 11.6 11.74
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 1.13 11.39 11.6 11.74
Others 6.23 62.21 62.04 61.9
Total 100 100 100 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Bafna Pharma 27.04 4.97 27.04 5.25 63.97 42.47 -25.20
Sun Pharma 484.35 -0.27 564.90 315.20 116211.79 12,531.93 3,211.14
Dr Reddys Labs 5015.90 -0.15 5514.65 2497.60 83399.01 11,850.40 2,937.70
Divis Labs 3067.25 -0.60 3388.00 1627.15 81425.85 5,310.57 1,372.71
Cipla 756.85 -0.07 829.00 356.75 61029.79 12,659.15 2,318.17

COMPANY OVERVIEW

Bafna PharmaceuticalsLtd is engaged in the production of tablets , capsule and oral syrup. The company is currently focusing on prescription drugs in the global market and contract manufacturing and dossier filing in regulated markets.Their product range includes Antibacterials,Antipyretics,Anticonvulsants,Anxiolytics,Pain management,Anthelmintics,Antifungal,Appetite stimulants,Antidiarrhoeals,Antiemetics,Hypnotics,Antacids and antiulcerants,Vitamin and dietery preparation,Cough and cold preparations,Antiasthmatics,Calcium preparations,Antihypertensives& Antidiabetics

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Bafna Mahaveer Chand

      Chairman & Managing Director

    • Paras Bafna

      Whole Time Director

    • V Rajamani

      Ind. Non-Executive Director

    • Babulal Kamlesh Kumar

      Ind. Non-Executive Director

    • Sunil Bafna

      Ind. Non-Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Bafna Pharmaceuticals Ltd.

Bafna Pharma is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 532989 and the NSE with an NSE Code of BAFNAPHARM.

Related Searches